Related references
Note: Only part of the references are listed.Myoepithelioma-like Hyalinizing Epithelioid Tumor of the Foot Harboring an OGT-FOXO1 Fusion
Takashi Yorozu et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)
Myoepithelioma-like Hyalinizing Epithelioid Tumors of the Hand With Novel OGT-FOXO3 Fusions
Jen-Chieh Lee et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
SRF-FOXO1 and SRF-NCOA1 Fusion Genes Delineate a Distinctive Subset of Well-differentiated Rhabdomyosarcoma
Marie Karanian et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
FOXO Signaling Pathways as Therapeutic Targets in Cancer
Mohd Farhan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)
Protein O-GlcNAcylation: emerging mechanisms and functions
Xiaoyong Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Unusual Signal Patterns of Break-apart FISH Probes Used in the Diagnosis of Soft Tissue Sarcomas
Gergo Papp et al.
PATHOLOGY & ONCOLOGY RESEARCH (2017)
Myoepithelioma-like Tumors of the Vulvar Region A Distinctive Group of SMARCB1-deficient Neoplasms
Akihiko Yoshida et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Novel FUS-KLF17 and EWSR1-KLF17 Fusions in Myoepithelial Tumors
Shih-Chiang Huang et al.
GENES CHROMOSOMES & CANCER (2015)
Myoepithelial Neoplasms of Soft Tissue: An Updated Review of the Clinicopathologic, Immunophenotypic, and Genetic Features
Vickie Y. Jo et al.
HEAD & NECK PATHOLOGY (2015)
Anchored multiplex FOR for targeted next-generation sequencing
Zongli Zheng et al.
NATURE MEDICINE (2014)
FOXO1: A Potential Target for Human Diseases
Huarui Lu et al.
CURRENT DRUG TARGETS (2011)
Resist or die FOXO transcription factors determine the cellular response to chemotherapy
Ana R. Gomes et al.
CELL CYCLE (2008)
PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma:: A report from the children's oncology group
PHB Sorensen et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Share Paper
